Valneva’s Contributions to Global Chikungunya Research and Vaccines at Scientific Conferences in 2023

2023-10-11 19:37:08

Oct 11, 2023, 1296 characters

Valneva will present at several scientific conferences in Q4 2023 on the mosquito-borne disease Chikungunya. At IDWeek, the annual meeting of the Infectious Diseases Society of America (IDSA), Valneva will sponsor a panel entitled “Chikungunya is an Increasing Global Threat: The Need for Better Protection,” on October 14, 2023 at 6:00 p.m EDT in Boston, Massachusetts.

At the American Society of Tropical Medicine and Hygiene (ASTMH) 2023 Annual Meeting in Chicago, Illinois, Valneva will give two presentations on chikungunya (at 11:00 a.m. and 12:15 p.m. CDT, respectively).

At the World Vaccine Congress Europe, October 16-19, 2023, in Barcelona, ​​Spain, Valneva will present a poster entitled “Safety of Live Attenuated Vaccines in Immunocompromised Patients and Pregnant Women: A Systematic Review.”

At the International Society of Vaccines Annual Congress, taking place in Lausanne, Switzerland, Valneva will present on Chikungunya on October 24, 2023 at 9:45 a.m. CEST.

Valneva will also be at the European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), which will take place from November 12th to 15th, 2023 in Copenhagen, Denmark.

BSN Podcasts

Christian Drastil: Vienna Stock Exchange chat

Vienna Stock Exchange Chat #502: Thank you Elis Karner, Paul Rettenbacher and Oliver Glasner, no risk / no fun at EuroTeleSites




Photo credit

1. Valneva, laboratory, vaccine, Credit: Valneva , (© Sender) >> Open on photaq.com

Stocks on the radar: CA Immo, Telekom Austria, EVN, Austriacard Holdings AG, UBM, voestalpine, Verbund, Rosgix, RBI, EuroTeleSites AG, Kapsch TrafficCom, Vienna Airport, Cleen Energy, DO&CO, Gurktaler AG Stamm, Josef Manner & Comp. AG, Agrana, Amag, Immofinanz, Austrian Post, Polytec Group, Semperit, Strabag, Uniqa, VIG.

Random Partner

Yes, yes
S Immo AG is a real estate investment company that has been listed on the Vienna Stock Exchange since 1987. The company invests 100 percent in the European Union and focuses on capitals in Austria, Germany and CEE. The portfolio consists of offices, shopping centers, hotels and residential properties.

>> Visit 67 other partners at boerse-social.com/partner


Valneva, laboratory, vaccine, Credit: Valneva, (© issuer)

Author Christine Petzwinkler

Stock exchange social network/magazine


1697061566
#Valneva #lectures #Chikungunya #conferences #USA #Europe

Leave a Replay